NanoTemper Technologies Acquires Envue Technologies
November 6, 2025
NanoTemper Technologies has acquired Envue Technologies, a Swedish spinout that developed Nanofluidic Scattering Microscopy (NSM), to expand its single-molecule and label-free analysis capabilities. The deal integrates Envue's NSM technology into NanoTemper's biophysical analysis portfolio and coincides with NanoTemper's launch of the Dianthus α application to enhance early-stage drug discovery workflows.
- Buyers
- NanoTemper Technologies
- Targets
- Envue Technologies
- Industry
- Biotechnology
- Location
- Västra Götaland County, Sweden
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
NanoVibronix, Inc. Acquires ENvue Medical Holdings Corp.
February 14, 2025
Medical Devices
NanoVibronix, Inc. (NASDAQ: NAOV) completed a stock-for-stock acquisition of ENvue Medical Holdings Corp., adding ENvue's FDA 510(k)-cleared electromagnetic navigation enteral feeding system to NanoVibronix's medical device portfolio. The transaction, which issued NanoVibronix common and Series X preferred shares to ENvue holders and was accompanied by a $500,000 senior convertible debenture private placement, is intended to expand commercial reach, product capabilities and operational efficiencies in enteral feeding and guided medical navigation.
-
Vorsana Environmental Acquires NanosTech
April 14, 2021
Energy
Vorsana Environmental Inc. has acquired NanosTech, a University of Calgary–linked developer of nano-catalyst in-situ upgrading technology (ISUT). The acquisition strengthens Vorsana’s cleantech portfolio—combining NanosTech’s catalytic upgrading and ISUT with Vorsana’s waste-to-fuel and carbon capture technologies to accelerate commercialization and reduce GHG emissions in Canada’s energy sector.
-
Bruker Corporation Acquires NanoString Technologies Business
May 6, 2024
Medical Devices
Bruker Corporation has acquired substantially all assets of NanoString Technologies, Inc. through a court-supervised Chapter 11 asset sale for approximately $392.6 million in cash plus assumption of certain liabilities. The deal, announced April 2024 and closed in late April/early May 2024, brings NanoString's spatial biology and gene-expression product lines into Bruker to preserve customer access, product development, and jobs while expanding Bruker's life‑science instrumentation capabilities.
-
Unchained Labs Acquires NanoView Biosciences
May 4, 2022
Biotechnology
Unchained Labs, a life-sciences tools company based in Pleasanton, California, acquired NanoView Biosciences to add exosome and viral-vector characterization technologies (ExoView and LentiView) to its product portfolio. The acquisition expands Unchained Labs' capabilities for gene therapy and biologics researchers by integrating NanoView's microchip-based interferometry and fluorescence platforms.
-
Medtronic Acquires Nano Surface Technology Assets from Nanovis
February 12, 2025
Medical Devices
Medtronic plc acquired certain nano surface technology assets and related IP rights from Columbia City, Indiana-based Nanovis to support development of next-generation PEEK interbody fusion devices. Financial terms were not disclosed; the deal transfers Nanovis’ bone-growth nanotechnology (including rights related to Sites Medical’s OsteoSync titanium pads) to Medtronic for integration into its spinal implant portfolio.
-
Scienta Scientific AB Acquires Envinet GmbH
March 31, 2021
Environmental Services
Scienta Scientific AB acquired Envinet GmbH, a Munich-based market leader in area monitoring radiation protection networks, effective March 31, 2021. The deal combines Envinet's gamma radiation detection networks with Scienta's airborne xenon detection capabilities to form a new Environmental Protection application area under the joint brand Scienta Envinet, strengthening Scienta's radiation protection solutions and global sales and service reach.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.